The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism

Yoichiro Mitsuishi1, Hozumi Motohashi, Masayuki Yamamoto

  • 1Department of Medical Biochemistry, Tohoku University Graduate School of Medicine Sendai, Japan ; Department of Respiratory Medicine, Tohoku University Graduate School of Medicine Sendai, Japan.

Frontiers in Oncology
|December 29, 2012
PubMed

Insights

The Keap1-Nrf2 pathway protects cells from stress. In cancer, Nrf2 stabilization promotes growth and resistance, suggesting Nrf2 inhibitors could be a therapeutic strategy.

Area of Science:

  • Cellular biology
  • Molecular mechanisms
  • Cancer research

Background:

  • The Keap1-Nrf2 pathway is crucial for cellular defense against oxidative and xenobiotic stresses.
  • Nrf2, a transcription factor, activates protective genes by binding to the antioxidant response element (ARE).
  • Under normal conditions, Keap1 targets Nrf2 for degradation; however, stress stabilizes Nrf2, leading to nuclear translocation and gene activation.

Purpose of the Study:

  • To review the Keap1-Nrf2 system's role in physiological and pathological conditions, particularly in cancer.
  • To present findings on Nrf2's function in cancer cell metabolism.
  • To discuss the therapeutic potential of targeting Nrf2 in cancer treatment.

Main Methods:

  • Literature review of the Keap1-Nrf2 pathway.
  • Analysis of Nrf2's role in cancer cell metabolism.
  • Discussion of Nrf2's impact on chemo- and radio-resistance.

Main Results:

  • Constitutive Nrf2 stabilization is observed in many human cancers, correlating with poor prognosis.
  • Nrf2 enhances cancer cell chemo- and radio-resistance through its antioxidant and detoxification functions.
  • Nrf2 likely promotes cancer cell growth by boosting cytoprotection and anabolism.

Conclusions:

  • The Keap1-Nrf2 pathway is a key player in cancer progression and treatment resistance.
  • Targeting Nrf2 may offer a promising strategy for cancer therapy.
  • Further research into Nrf2's metabolic functions could reveal new therapeutic avenues.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Other Stress Responses in Bacteria01:30

Other Stress Responses in Bacteria

Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...